Abstract
Natural killer (NK) cells are involved in innate defense against viral infection and cancer. NK cells can be divided into subsets based on the ability of different receptors to bind to major histocompatibility (MHC) class 1 molecules, resulting in differential responses upon activation in a process called “licensing” or “arming.” NK cells expressing receptors that bind self-MHC are considered licensed due to an augmented effector lytic function capability compared with unlicensed subsets. However, we demonstrated that unlicensed NK subsets instead positively regulate the adaptive T-cell response during viral infections that are related to localization and cytokine production. In this study, the differential effects of the two types of NK subsets were contingent on the environment in viral infection and hematopoietic stem cell transplantation (HSCT) models. Infection of mice with high-dose (HD) murine cytomegalovirus (MCMC) led to a loss of licensing-associated differences, as compared with mice with low-dose (LD) infection: the unlicensed NK subset no longer localized in lymph nodes (LNs), but instead remained at the site of infection. Similarly, the patterns observed during HD infection paralleled the phenotypes of both human and mouse NK cells in an HSCT setting where NK cells exhibit an activated phenotype. However, in contrast to the effects of subset depletion in T-cell replete models, the licensed NK cell subsets still dominated antiviral responses after HSCT. Overall, our results highlight the intricate tuning of NK cells and how it affects overall immune responses with regard to licensing patterns and their dependency on the level of stimulation and activation status.
Original language | English (US) |
---|---|
Pages (from-to) | 4219-4232 |
Number of pages | 14 |
Journal | Blood Advances |
Volume | 5 |
Issue number | 20 |
DOIs | |
State | Published - Oct 26 2021 |
Bibliographical note
Funding Information:This work was supported in part by National Institutes of Health, National Heart, Lung, and Blood Institute grant R01HL140921 (W.J.M.) and in part by funds from the UCD Comprehensive Cancer Center and the UCD Flow Cytometry Shared Resource Laboratory, with funding from National Cancer Institute grant P30CA093373 (Cancer Center) and National Center for
Funding Information:
This work was supported in part by National Institutes of Health, National Heart, Lung, and Blood Institute grant R01HL140921 (W.J.M.) and in part by funds from the UCD Comprehensive Cancer Center and the UCD Flow Cytometry Shared Resource Laboratory, with funding from National Cancer Institute grant P30CA093373 (Cancer Center) and National Center for Research Resources grant S10RR026825 (Fortessa Cytometer). We would like to thank the NIH tetramer core facility at Emory University for providing the tetramers utilized in the studies.
Publisher Copyright:
© 2021 by The American Society of Hematology.